Joshua D Rosenblat Selected Research

Ketamine

4/2024	Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis.
4/2024	Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
1/2024	Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression.
12/2023	The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.
10/2023	Real-World Effectiveness of Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression.
9/2023	Oral ketamine for depression: An updated systematic review.
2/2023	The therapeutic role of ketamine and esketamine in treating psychopathological domains of depression.
1/2023	A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study).
1/2023	Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youth.
1/2023	Biomarkers of ketamine's antidepressant effect: An umbrella review.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joshua D Rosenblat Research Topics

Disease

46	Treatment-Resistant Depressive Disorder 04/2024 - 01/2019
44	Major Depressive Disorder (Major Depressive Disorders) 04/2024 - 09/2013
35	Bipolar Disorder (Manic Depressive Psychosis) 10/2023 - 08/2014
23	Mood Disorders (Mood Disorder) 04/2024 - 08/2014
13	Inflammation (Inflammations) 04/2024 - 05/2016
11	Cognitive Dysfunction 04/2024 - 01/2014
9	Anhedonia 02/2023 - 05/2016
9	Mental Disorders (Mental Disorder) 01/2023 - 06/2017
6	Schizophrenia (Dementia Praecox) 01/2022 - 08/2018
4	Headache (Headaches) 01/2024 - 01/2021
4	Nausea 01/2024 - 01/2021
4	Substance-Related Disorders (Drug Abuse) 08/2023 - 01/2022
4	Depressive Disorder (Melancholia) 01/2023 - 01/2019
4	COVID-19 01/2022 - 01/2020
4	Mania (Manias) 12/2020 - 04/2017
3	Postpartum Depression (Post-Natal Depression) 01/2024 - 11/2022
3	Neoplasms (Cancer) 01/2023 - 01/2018
3	Insulin Resistance 01/2023 - 01/2021
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2019
3	Hypertension (High Blood Pressure) 11/2021 - 01/2020
3	Obesity 01/2020 - 01/2019
2	Fatigue 02/2024 - 01/2023
2	Weight Gain 01/2024 - 01/2022
2	Neurobehavioral Manifestations 10/2022 - 01/2019
2	Psychomotor Agitation (Akathisia) 01/2022 - 01/2022
2	Alcoholism (Alcohol Abuse) 01/2021 - 01/2018
2	Neuroinflammatory Diseases 01/2020 - 11/2018
2	Alzheimer Disease (Alzheimer's Disease) 11/2018 - 10/2018
1	Dizziness (Lightheadedness) 01/2024
1	Dysgeusia (Parageusia) 01/2023
1	Vomiting 01/2023
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2023
1	Post-Acute COVID-19 Syndrome 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 12/2022
1	Metabolic Bone Diseases (Osteopenia) 12/2022
1	Death (Near-Death Experience) 11/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2022
1	Perceptual Disorders (Hemispatial Neglect) 06/2022
1	Hallucinations (Hallucination) 06/2022
1	Infections 01/2022
1	Obstructive Sleep Apnea 01/2022
1	Tardive Dyskinesia 12/2021
1	Pain (Aches) 11/2021

Drug/Important Bio-Agent (IBA)

58	Ketamine FDA LinkGeneric 04/2024 - 02/2016
44	Antidepressive Agents (Antidepressants)IBA 01/2024 - 07/2015
14	EsketamineIBA 04/2024 - 01/2020
10	Psilocybin (Psilocibin)IBA 04/2024 - 01/2021
8	VortioxetineIBA 04/2024 - 11/2019
8	Infliximab (Remicade)FDA Link 11/2022 - 01/2019
7	Hallucinogens (Psychedelics)IBA 04/2024 - 01/2021
6	CytokinesIBA 01/2022 - 08/2014
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 11/2018
5	Antipsychotic Agents (Antipsychotics)IBA 01/2022 - 04/2017
5	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 10/2019 - 08/2014
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2024 - 01/2018
4	Glutamic Acid (Glutamate)FDA Link 09/2023 - 01/2018
4	Therapeutic UsesIBA 11/2022 - 01/2020
3	C-Reactive ProteinIBA 04/2024 - 12/2015
3	Lysergic Acid Diethylamide (LSD)IBA 04/2024 - 01/2021
3	zuranoloneIBA 01/2024 - 11/2019
3	LithiumIBA 01/2024 - 12/2020
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 10/2020
3	Insulin (Novolin)FDA Link 01/2021 - 01/2014
2	Tuberculin (PPD)IBA 01/2024 - 11/2022
2	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2024 - 11/2021
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 09/2023 - 01/2019
2	Escitalopram FDA Link 01/2023 - 01/2019
2	VaccinesIBA 01/2023 - 01/2022
2	3-carboxamido-4-hydroxynaltrexoneIBA 01/2022 - 04/2018
2	Valproic Acid (Depakote)FDA LinkGeneric 01/2022 - 12/2020
2	Anesthetics (Anesthetic Agents)IBA 11/2021 - 04/2021
2	LeptinIBA 10/2020 - 01/2020
2	Minocycline (Cyclops)FDA LinkGeneric 10/2019 - 08/2014
2	gamma-Aminobutyric Acid (GABA)IBA 11/2018 - 08/2018
2	Hypoglycemic Agents (Hypoglycemics)IBA 10/2018 - 09/2013
2	KynurenineIBA 08/2018 - 01/2017
2	Glutamine (L-Glutamine)FDA Link 08/2018 - 01/2018
2	Tryptophan (L-Tryptophan)FDA Link 08/2018 - 01/2017
2	sapropterin (tetrahydrobiopterin)FDA Link 01/2017 - 05/2016
1	cariprazineIBA 04/2024
1	Psychotropic Drugs (Psychoactive Drugs)IBA 01/2024
1	Phosphorus (Red Phosphorus)IBA 12/2022
1	MineralsIBA 12/2022
1	Olanzapine (Zyprexa)FDA Link 01/2022
1	AntibodiesIBA 01/2022
1	ProlactinIBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	lumateperoneIBA 01/2022
1	Trace amine-associated receptor 1IBA 12/2021
1	SEP-363856IBA 12/2021
1	Pentoxifylline (Trental)FDA LinkGeneric 10/2021
1	PlacebosIBA 10/2021

Therapy/Procedure

9	Therapeutics 03/2024 - 08/2014
4	Drug Therapy (Chemotherapy) 04/2023 - 01/2019
1	Investigational Therapies (Experimental Therapy) 01/2024
1	Palliative Care (Palliative Therapy) 01/2023
1	Protein-Restricted Diet (Diet, Protein Restricted) 01/2023
1	Pain Management 11/2021
1	Anesthesia 11/2021